The recombinant antigen expression platform uses genetic engineering technologies to develop tools and methods that produce protein antigens needed for vaccines and antibodies. The basic principle requires inserting target antigen gene sequences into suitable expression vectors to produce substantial amounts of recombinant protein antigens through host cell expression. Creative Diagnostics offers its recombinant antigen expression platform to support the production of vaccines and antibodies using recombinant antigens. Our recombinant antigen expression technology delivers efficient antigen production with consistent batch quality while offering modular methods for different scientific research demands.
ACQUITY UPLC H-Class PLUS
FPLC System
Surface plasmon resonance (SPR)
With decades of expertise and a reputation as a trusted leader in recombinant antigen production, Creative Diagnostics delivers tailored solutions that meet the unique needs of every customer. Our technical excellence spans the full spectrum of antibody and antigen production, cutting-edge diagnostic component innovation, and advanced reagent development. From concept to application, we empower the diagnostics industry with reliable, forward-thinking support. We offer:
To meet the increasingly diverse needs of scientists and product developers, Creative Diagnostics has devoted itself to creating professional recombinant antigen development solutions based on advanced recombinant antigen expression platforms. We combine cutting-edge technologies and innovative strategies to ensure the efficiency, reliability and accuracy of the recombinant antigen generation process. Our services include:
According to the characteristics of the target antigen, design and optimize its gene sequence to improve its solubility and expression efficiency in the expression system. For example, codon optimization is used to enhance expression in the prokaryotic system.
Insert the optimized antigen gene into a suitable expression vector to construct a recombinant plasmid. Commonly used expression vectors include pSectag, pGenHT, etc. These vectors usually contain elements such as promoters and signal peptides to promote the correct expression and translation of the antigen.
Select suitable host cells such as Escherichia coli, yeast, insect cells or mammalian cells (such as CHO cells) according to the nature and expression requirements of the antigen. Introduce the recombinant plasmid into the host cell by transfection or infection.
Under appropriate culture conditions, induce host cells to express the target antigen. For example, protein expression can be induced by adding IPTG in Escherichia coli, while specific inducers or conditions may be required in mammalian cells.
Cells are lysed by centrifugation, ultrasonic disruption, etc. to extract the target antigen. Subsequently, the target antigen is purified by affinity chromatography (such as His-tag, GST-tag), ion exchange chromatography, gel filtration chromatography and other methods to obtain high-purity recombinant antigens.
The purified antigen is quality tested, including SDS-PAGE, Western blot, ELISA and other methods to ensure its purity, activity and consistency. Finally, the high-quality recombinant antigen is delivered to the customer or used for further vaccine or diagnostic reagent development.
For large-scale production, it is usually necessary to construct a stable expression cell line and achieve efficient production of antigens through fermentation technology.
In the development of vaccines or diagnostic reagents, the functions of recombinant antigens, such as immunogenicity, epitope coverage, stability, etc., also need to be verified.
Communicate the target antigen type, determine the expression system, target gene sequence, and optimize the target gene sequence analysis.
Expression test in selected host cells to evaluate antigen characteristics.
Expand the production scale of verified antigens according to customer needs.
Provide endotoxin level detection and antigen activity detection services.
Lyophilization, buffer configuration, detailed technical report and COA according to customer needs.
Creative Diagnostics expressed the full-length recombinant Cyclin B1 antigen, and then tested the samples at different expression stages by SDS-PAGE. The results showed that Cyclin B1 was successfully expressed and purified with good results.
This figure shows the immunological activity of recombinant p53 antigen verified by ELISA. The yellow curve and dots represent the OD450 test results after the antibody binds to the coated p53 antigen; the red dotted line indicates the linear detection range (about 0.5–10 ng/mL), which is suitable for quantitative analysis; the gray dotted line represents the antibody binding plateau (saturation signal), indicating that the antigen has good binding ability. Results show that the recombinant p53 antigen has good immunological activity, high detection sensitivity and a clear linear response range.
A Recombinant Antigen Expression Platform is a comprehensive set of systematic methods leveraging genetic engineering technology. Its core purpose is to efficiently and controllably express protein antigens for vaccine and antibody development, as well as disease - related research.
Initially in the working process gene cloning takes place which involves isolating the gene sequence responsible for encoding the target antigen. The next step involves selecting a suitable expression vector which includes options like bacterial plasmids, viral vectors, or artificial chromosomes. The expression vector receives the target gene during the genetic engineering process. The development process requires choosing a suitable host cell system that could include Escherichia coli, yeast cells, insect cells or mammalian cells. Scientists introduce the target gene vector into the host cells. The recombinant protein antigen emerges from the host cells by using optimized expression conditions. Scientists first purify the produced protein then they proceed to verify its quality. The process produces protein antigens on a large scale and maintains their high purity, functional retention and structural integrity.
Vaccine development: Production of recombinant protein vaccines and virus-like particle (VLP) vaccines requires this essential process. These vaccine types offer enhanced safety and stability compared to traditional vaccines because they present only essential antigenic components.
Diagnostic reagent development: Immunoassay methods such as ELISA and colloidal gold utilize recombinant antigens together with immunoaffinity column chromatography. Using these technologies offers a precise and dependable method for disease detection.
Basic research: The platform supports high-throughput production of multiple antibodies crucial for immune system research and drug target screening.
Production of therapeutic antibodies: The platform accommodates all stages from fundamental research to antibody - based treatments. Customization based on precise application needs leads to the creation of very specific therapeutic antibodies.
Creative Diagnostics stands out for several reasons. The company possesses extensive experience in recombinant antigen production which demonstrates its deep technical understanding and ability to manage complicated projects.
Our expression system functions across multiple platforms. Protein complexity requirements can be met through this flexible platform which supports both simple proteins and highly glycosylated proteins. The company delivers comprehensive expression systems with options to select host systems which produce proteins retaining their natural shape and functional properties along with immunogenic qualities.
Advanced techniques such as codon optimization, custom expression vector construction, and fusion tag design are used to enhance expression and purity. Additionally, it uses advanced synthetic biology tools to improve the success rate of expressing difficult - to - express proteins or membrane proteins. Rigorous quality control through various methods like SDS - PAGE, Western Blot, and Mass Spectrometry guarantees high - quality products. It also offers full - process services from small - scale R & D to large - scale production.
For high affinity antibody development using our Recombinant Antigen Expression Platform, please contact your expert antibody manufacturer, Creative Diagnostics. From research-grade tools to industrial-scale antibody production, our team is ready to support your R&D innovation.
